Turning plastic waste into a valuable resource: Epoch Biodesign

UK-based Epoch Biodesign has announced an oversubscribed $18.3M Series A funding round, aimed at building their first commercial-scale plant to tackle plastic waste. This funding, which includes participation from Inditex and a $1M grant from the UK government, will enable Epoch to expand their enzyme technology for recycling. The company focuses on enzymatic recycling to transform plastics into reusable monomers, addressing the urgent need for solutions to the plastic waste crisis.